Evidence map›Paper›PMID 28217966›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2017

Pathogenesis of Diffuse Alveolar Hemorrhage in Murine Lupus.

Haoyang Zhuang, Shuhong Han, Pui Y Lee, Ravil Khaybullin, Stepan Shumyak, Li Lu, Amina Chatha, Anan Afaneh, Yuan Zhang, Chao Xie and 5 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. PARP7 protects the lung epithelial barrier from diverse environmental threats.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Haoyang ZhuangUniversity of Florida, Gainesville.
Shuhong HanUniversity of Florida, Gainesville.
Pui Y LeeBoston Children's Hospital, Boston, Massachusetts.
Ravil KhaybullinUniversity of Florida, Gainesville.
Stepan ShumyakUniversity of Florida, Gainesville.
Li LuUniversity of Florida, Gainesville.
Amina ChathaUniversity of Florida, Gainesville.
Anan AfanehUniversity of Florida, Gainesville.
Yuan ZhangUniversity of Florida, Gainesville.
Chao XieUniversity of Florida, Gainesville.
Dina NacionalesUniversity of Florida, Gainesville.
Lyle MoldawerUniversity of Florida, Gainesville.
Xin QiUniversity of Florida, Gainesville.
Li-Jun YangUniversity of Florida, Gainesville.
Westley H ReevesUniversity of Florida, Gainesville.
University of Florida · USBoston Children's Museum · US

Funding

Pathogenesis on Autoantibodies in Pristane-Induced LupusR01AR044731 · NIAMS · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI REEVES, WESTLEY H · 1997 to 2021
$6.6M
REGULATION ON MONOKINE PRODUCTION IN TRAUMA AND SURGERYR01GM040586 · NIGMS · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI MOLDAWER, LYLE L · 1988 to 2016
$2.6M
NIAMS NIH HHS R01 AR044731NIGMS NIH HHS R01 GM040586
6 · The paper itself

Abstract

objectiveDiffuse alveolar hemorrhage (DAH) in lupus patients confers >50% mortality, and the cause is unknown. We undertook this study to examine the pathogenesis of DAH in C57BL/6 mice with pristane-induced lupus, a model of human lupus-associated DAH.

methodsClinical/pathologic and immunologic manifestations of DAH in pristane-induced lupus were compared with those of DAH in humans. Tissue distribution of pristane was examined by mass spectrometry. Cell types responsible for disease were determined by in vivo depletion using clodronate liposomes and antineutrophil monoclonal antibodies (anti-Ly-6G). The effect of complement depletion with cobra venom factor (CVF) was examined.

resultsAfter intraperitoneal injection, pristane migrated to the lung, causing cell death, small vessel vasculitis, and alveolar hemorrhage similar to that seen in DAH in humans. B cell-deficient mice were resistant to induction of DAH, but susceptibility was restored by infusing IgM. C3

conclusionThe pathogenesis of DAH involves opsonization of dead cells by natural IgM and complement followed by complement receptor-mediated lung inflammation. The disease is macrophage dependent, and IL-10 is protective. Complement inhibition and/or macrophage-targeted therapies may reduce mortality in lupus-associated DAH.

Indexed as

AnimalsDisease Models, AnimalFemaleHemorrhageHumansInterleukin-10LungLung DiseasesLupus Erythematosus, SystemicMacrophage ActivationMacrophagesMiceMice, Inbred C57BLPulmonary AlveoliTerpenesInterleukin-10pristaneTerpenes

Identifiers

PMID28217966
PMCPMC5449234
OpenAlexW2589030186

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.